Publication Venue For

  • Assessment and clinical utility of pharmacogenomics by healthcare practitioners in North Carolina.  22:13-25. 2021
  • Between a rock and a hard place: A high-risk patient with resistance to multiple P2Y12 antagonists.  20:475-481. 2019
  • Pharmacogenetics of warfarin dosing in patients of African and European ancestry.  19:1357-1371. 2018
  • SLC04A1, SLC22A2 and SLC28A2 variants not related to methotrexate efficacy or toxicity in rheumatoid arthritis patients.  19:613-619. 2018
  • An epigenome-wide association study of inflammatory response to fenofibrate in the Genetics of Lipid Lowering Drugs and Diet Network.  18:1333-1341. 2017
  • Influence of common and rare genetic variation on warfarin dose among African-Americans and European-Americans using the exome array.  18:1059-1073. 2017
  • Genome-wide association study of warfarin maintenance dose in a Brazilian sample.  16:1253-1263. 2015
  • Copy-number analysis of topoisomerase and thymidylate synthase genes in frozen and FFPE DNAs of colorectal cancers.  9:1459-1466. 2008
  • Ethnic differences in warfarin maintenance dose requirement and its relationship with genetics.  9:1331-1346. 2008
  • VKORC1 polymorphims, haplotypes and haplotype groups on warfarin dose among African-Americans and European-Americans.  9:1445-1458. 2008
  • Pharmacogenetics of etanercept in rheumatoid arthritis.  9:1011-1015. 2008
  • Influence of CYP2C9 and VKORC1 on warfarin dose, anticoagulation attainment and maintenance among European-Americans and African-Americans.  9:511-526. 2008
  • International Standard Serial Number (issn)

  • 1462-2416
  • Electronic International Standard Serial Number (eissn)

  • 1744-8042